Education > Webinar > Vanessa Stadlbauer-Köllner | The gut-liver axis as a novel therapeutic target in chronic liver disease

Vanessa Stadlbauer-Köllner | The gut-liver axis as a novel therapeutic target in chronic liver disease

- Learn background information on the burden of chronic liver disease and on gut microbiome composition - Understand the alterations in the gut-liver axis in chronic liver diseases - Discover methods to alter the gut-liver axis - Learn about safety and efficacy of probiotics in chronic liver disease

When
1st May 2019

This content is for verified practitioners only

Please create an account and login to view this educational resource.

Login / Register

Related Articles

Introducing Invivo's #GutGardenChallenge

Liver cirrhosis is an increasingly common disease with high rates of complications, leading to high burden of disease for patients, their relatives and the health care system. Liver cirrhosis is ...

GI Microbiome, Microbiome 101, Microbiome Basics, Supplements
Prebiotics: You are what your microbes eat.

Liver cirrhosis is an increasingly common disease with high rates of complications, leading to high burden of disease for patients, their relatives and the health care system. Liver cirrhosis is ...

Microbiome Basics, Microbiome How To's, Supplements
How To Support Your Microbiome in Autumn

With the arrival of autumn, there's a renewed emphasis on the well-being of your microbiome. Just as the leaves undergo a transformation during this season, it's time to consider a ...